Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA: 600222)

China flag China · Delayed Price · Currency is CNY
5.18
-0.10 (-1.89%)
Dec 25, 2024, 3:00 PM CST
-14.94%
Market Cap 2.86B
Revenue (ttm) 1.97B
Net Income (ttm) 89.38M
Shares Out 554.67M
EPS (ttm) 0.16
PE Ratio 32.10
Forward PE n/a
Dividend 0.02 (0.35%)
Ex-Dividend Date Dec 9, 2024
Volume 16,884,441
Open 5.31
Previous Close 5.28
Day's Range 5.15 - 5.35
52-Week Range 3.75 - 6.33
Beta 0.65
Analysts n/a
Price Target n/a
Earnings Date Mar 27, 2025

About Henan Taloph Pharmaceutical Stock Co.,Ltd

Henan Taloph Pharmaceutical Stock Co.,Ltd engages in the research, development, and sale of pharmaceutical preparations and Chinese herbal medicines in China. Its principal products include Shuanghuanglian oral liquid series, Shuangjinlian mixture, Danshen oral liquid, pediatric heat-clearing and cough-relieving oral liquid, pediatric compound chicken gizzard chewable tablets, and Huperzine A tablets. The company serves hospitals, primary medical institutions, and retail terminals. The company was formerly known as Henan Joyline & Joysun Pharma... [Read more]

Sector Healthcare
Founded 1993
Employees 2,353
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600222
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.